Nova Biogenics Private Limited - Company Profile

It is a other industry private limited company based in New Delhi, Delhi, India, established in 1989.
1989 New Delhi, Delhi, India Converted to LLP
Last Updated:
Access Report
About Nova Biogenics Private Limited

Nova Biogenics Private Limited, a converted to llp private limited company, was established on 28 February 1989 in New Delhi, Delhi, India. Engaging in other services within the other industry sector, it holds CIN: U24239DL1989PTC035274. Registered under ROC Roc Delhi. it is unlisted. It has an authorized capital of ₹1.00 M and a paid-up capital of ₹0.30 M.

Its leadership includes Kamal Kumar Oswal (Director), Primal Oswal (Director). Its latest AGM occurred on 23 September 2014, with the balance sheet filed on 31 March 2014. It is based at 304,Meghdoot Building 94, Nehru Place, New Delhi, Delhi, 110019.

Company Details
  • Email
    **********
  • Telephone

    +91-XXXXXXXXXX

  • Website
    **********
  • Social Media
    **********
  • Apps
    **********

Company Details

  • CIN/LLPIN

    U24239DL1989PTC035274

  • Registration Number

    035274

  • Incorporation Date

    28 February 1989

  • Authorized Capital

    ₹1.00 M

  • Paid-Up Capital

    ₹0.30 M

  • ROC Code

    Roc Delhi

  • Listing Status

    Unlisted

  • Company Status

    Converted to LLP

Key Metrics
  • Authorised Capital ₹ 1.00 M
  • Paid Up Capital ₹ 0.30 M
  • Company Age 37 Year,
  • Last Filing with ROC 31 Mar 2014
Company report

Nova Biogenics Private Limited

Company Report FY 2025-2026

Comprehensive Company Insights

Explore comprehensive insights into Nova Biogenics Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.

Access Report
Who are the key members and board of directors at Nova Biogenics Private Limited?
Current Directors
Name Designation Appointment Date Status
Kamal Kumar Oswal Director 01 Apr 1992 Current
Primal Oswal Director 01 Apr 1992 Current

Discover detailed profiles of directors and KMP - Unlock leadership insights today!

Financial Performance of Nova Biogenics.

Enhance accessibility to Nova Biogenics's financial data by unlocking access to both Standalone and Consolidated balance sheets, Profit & Loss Statements, Ratios, Related Party Transactions, and additional relevant information.

Nova Biogenics revenue growth over time
Nova Biogenics profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors
Emtek
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
Jan, 2021 Amount Post-IPO - Grab Valuation

investors
Hana Financial Group , GGV Capital
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
  • Key Matrics
  • Balance Sheet
  • Profit and Loss
  • Cash Flow
  • Ratios
Metrics
(FY 2023) YOY Growth
(FY 2022) (FY 2021) (FY 2020) (FY 2019)
Total Revenue
********
*******
*******
*******
*******
*******
Revenue from Operations
*******
*******
*******
*******
*******
*******
Total Assets
*******
*******
*******
*******
*******
*******
Profit or Loss
*******
*******
*******
*******
*******
*******
Net Worth
*******
*******
*******
*******
*******
*******
EBITDA
*******
*******
*******
*******
*******
*******

Discover detailed financial data and - Unlock financial today!

What is the Ownership and Shareholding Structure of Nova Biogenics?

Unlock access to Nova Biogenics's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.

Shareholding Pattern (FY 2024)
shareholding
  • Promoters: 92.83%
  • Public: 4.10%
  • Others: 3.07%
Shareholding Pattern over the Year
FY (2024) FY (2023) FY (2022) FY (2021) FY (2020)
Promoters 92.83 94.62 94.55 94.55 94.55
Public 4.10 3.89 3.95 3.96 3.98
Others 3.07 1.49 1.50 1.49 1.47

Reveal ownership structures and financial performance - Get instant access now!

How Many Employees Work at Nova Biogenics?

Unlock and access historical data on people associated with Nova Biogenics, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.

Employee Date Number of Employees
2020 78,000
2021 80,500
2022 83,200
2023 86,000
2024 89,500
2025 92,000
Deals i
Graph showing company valuation over time

Gain comprehensive insights into the Deals and Valuation data of Nova Biogenics, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Nova Biogenics's trajectory.

Rating
Graph displaying rating trends over time

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts
Alert Indicator

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Explore deal ratings and alerts - Get instant access now!

Latest Updates, News, and FAQs on Nova Biogenics
Recent Activity within the Organization
  • Annual General Meeting

    Nova Biogenics Private Limited last Annual general meeting of members was held on 23 Sep 2014 as per latest MCA records. was recorded as a recent event.

  • Balance Sheet

    The activity Nova Biogenics Private Limited has filed its annual Financial statements for the year ended 31 Mar 2014 with Roc Delhi. was completed.

  • Director Appointment

    Progress on Kamal Kumar Oswal was appointed as a Director was appointed as a Director on 01 Apr 1992 & has been associated with this company since 33 years 10 months . was documented.

  • Director Appointment

    The activity Primal Oswal was appointed as a Director was appointed as a Director on 01 Apr 1992 & has been associated with this company since 33 years 10 months . was completed.

  • Company Incorporation

    The activity Nova Biogenics Private Limited was registered on 28 Feb 1989 with Roc Delhi & aged 37 years as per MCA records. was completed.

Explore recent activity and updates - View Recent Activity

Frequently Asked Questions
What is the CIN of Nova Biogenics Private Limited?

The CIN of Nova Biogenics Private Limited is U24239DL1989PTC035274.

Where is Nova Biogenics Private Limited headquartered?

Nova Biogenics Private Limited is headquartered at 304,Meghdoot Building 94, Nehru Place, New Delhi, Delhi, 110019.

When was Nova Biogenics Private Limited incorporated?

Nova Biogenics Private Limited was incorporated on 28 February 1989.

Who are the current directors of Nova Biogenics Private Limited?

The current directors of Nova Biogenics Private Limited are

What is the primary industry of Nova Biogenics Private Limited?

The primary industry of Nova Biogenics Private Limited is Other Industry.

Is Nova Biogenics Private Limited a listed company?

Nova Biogenics Private Limited is unlisted.

What is the capital structure of Nova Biogenics Private Limited?

The authorized capital of Nova Biogenics Private Limited is ₹1.00 M, and the paid-up capital is ₹0.30 M.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available